(Reuters) - Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes.
via Health News Headlines - Yahoo News http://ift.tt/1kQDSFu
via Health News Headlines - Yahoo News http://ift.tt/1kQDSFu
No comments:
Post a Comment